资讯
Stryker has received 510(k) clearance from the FDA for its Incompass Total Ankle System, a next-generation implant targeting ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Stryker’s Incompass Total Ankle System, designed ...
Sititi, 22, was last year's World Rugby's Breakthrough Player of the Year but played a limited part in the Chiefs' Super ...
Stryker has secured FDA clearance for its Incompass total ankle system to treat patients whose ankle joints have been damaged by severe rheumatoid, post-traumatic or degenerative arthritis. The ...
Stryker (NYSE:SYK) announced today that it received FDA 510(k) clearance for its Incompass total ankle system.
Transfibular total ankle arthroplasty (TAA) seems effective and durable for end-stage ankle arthritis, according to a study published online.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果